Variation in gene expression patterns in human gastric cancers.
暂无分享,去创建一个
D. Botstein | P. Brown | O. Troyanskaya | S. So | J. Ji | Xin Chen | S. Leung | S. Yuen | K. Chu | Rui Li | A. S. Chan | S. Law | J. Wong
[1] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[2] D. Owen,et al. Carcinoma of the stomach in young persons , 1985, Cancer.
[3] P. Correa,et al. A human model of gastric carcinogenesis. , 1988, Cancer research.
[4] G. Friedman,et al. Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.
[5] D. Shibata,et al. Epstein-Barr virus-associated gastric adenocarcinoma. , 1992, The American journal of pathology.
[6] S. Leung,et al. In Situ Detection of Epstein‐Barr Virus in Gastric and Colorectal Adenocarcinomas , 1994, The American journal of surgical pathology.
[7] 胃癌研究会. Japanese classification of gastric carcinoma , 1995 .
[8] Arthur M Buchberg,et al. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasia , 1995, Cell.
[9] P. Chambon,et al. Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.
[10] J. Toretsky,et al. Involvement of IGF-II in human cancer. , 1996, The Journal of endocrinology.
[11] K. Kinzler,et al. Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.
[12] Eric S. Lander,et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis , 1997, Nature Genetics.
[13] S. Leung,et al. p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma. , 1998, Histopathology.
[14] J. Witte,et al. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Jacques Ferlay,et al. Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.
[16] D. Botstein,et al. The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.
[17] H. P. Wang,et al. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. , 2000, Gastroenterology.
[18] E. Pasquale,et al. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis , 2000, Oncogene.
[19] H. S. Kim,et al. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. , 2000, Cancer research.
[20] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[21] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[22] J. Sudbø,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[23] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[26] David Botstein,et al. Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.
[27] David Botstein,et al. The Stanford Microarray Database , 2001, Nucleic Acids Res..
[28] H. Frierson,et al. Expression profiling of gastric adenocarcinoma using cDNA array , 2001, International journal of cancer.
[29] Russ B. Altman,et al. Missing value estimation methods for DNA microarrays , 2001, Bioinform..
[30] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[31] Rui Li,et al. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] T. Poggio,et al. Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.
[33] L. Staudt,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[34] C. Ball,et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.
[35] Hans Clevers,et al. Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors , 2002, Molecular and Cellular Biology.
[36] K. Kullander,et al. Mechanisms and functions of eph and ephrin signalling , 2002, Nature Reviews Molecular Cell Biology.
[37] Tony Pawson,et al. β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.
[38] Russ B. Altman,et al. Nonparametric methods for identifying differentially expressed genes in microarray data , 2002, Bioinform..
[39] Shuichi Tsutsumi,et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. , 2002, Cancer research.
[40] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .